The Log
Archive
733 stories, newest first.
July 2026
- Jul 3Treatment & Recovery
The First Benzodiazepine Prescription Doesn't Look Like a Drug Problem. That's Exactly How It Becomes One.
A July 2026 study links initial benzodiazepine prescription length to years of use. The 1970s Valium era already proved how normalized dependence hides in plain sight — here's the biology, the history, and what to do if you're the one holding the bottle.
- Jul 3Science & Medicine
Seven Days Is the Line Between a Benzodiazepine Prescription and a Benzodiazepine Habit
A new PLOS Medicine cohort study of 1.8 million Ontario patients found initial benzodiazepine prescriptions over 7 days sharply lower the odds of ever stopping. Here's the data, the biology, and the limits.
- Jul 3Policy & Funding
The FDA Told You ZYN Is Safer Than Cigarettes. It Used to Say That About 'Light' Ones, Too.
The FDA authorized Swedish Match to market 20 ZYN products as lower-risk than cigarettes. Here's what that claim actually covers, why 460,000 kids already use pouches, and what the 2009 ban on 'light' cigarettes should have taught us first.
- Jul 3Technology & Innovation
Three Different Clocks Are Running Out on Mail-Order Ketamine, and Only One of Them Is About Safety
DEA's telehealth flexibility for ketamine runs through December 31, 2026, Texas wants to ban at-home use outright, and an FDA generic ketamine decision lands in between. Three regulatory gates, three different timelines.
- Jul 3Lived Experience & Community
The People HAMS Helped Aren't All Sober — And HAMS Calls That a Win
Ten HAMS members describe what actually changed their drinking — tracking, scheduling, and group accountability, not a single sobriety pledge. A look at moderation management as a legitimate harm-reduction lane.
- Jul 3Harm Reduction
DEA Just Scheduled an Opioid Ten Times Stronger Than Fentanyl. Your Test Strip Won't Catch It.
DEA quietly placed cychlorphine, a synthetic opioid roughly 10x fentanyl's potency and invisible to standard fentanyl test strips, into Schedule I on July 1 — the same day a bigger kratom scheduling story ate the coverage.
- Jul 3The Crisis, By the Numbers
The Country Is Winning the Overdose Fight. Arizona Is Losing It — and July Is When That Gets Worse.
National overdose deaths fell 13.2% to a generational low. Arizona rose 11.5% over the same year, and Maricopa County's deadliest overdose month, July, just started.
- Jul 2Science & Medicine
A Cancer Charity Took Alcohol Industry Money for Years. Then It Admitted There's No Safe Amount.
STAT News' investigation into alcohol-industry influence over public health messaging shows the American Cancer Society took gala donations for years while saying moderate drinking was safe — before reversing course in 2020. Here's what that pattern means for what you're told next.
- Jul 2Lived Experience & Community
Your Brain Learns Faster From a Craving Than From a Rule — That's Why 'One Slip, Total Failure' Backfires
Kenneth Anderson's HAMS members cut back on alcohol through tracking and non-shame reframing instead of abstinence rules — and new Yale craving research helps explain why all-or-nothing thinking works against the brain.
- Jul 2The Crisis, By the Numbers
The Border Fight Is a Distraction From the Real Fentanyl Story
CBP testified northern-border fentanyl seizures fell 55% while CDC data shows a 13.2% drop in overdose deaths — two very different stories, and only one matters for people trying to survive.
- Jul 2Policy & Funding
DEA Hears Cannabis Withdrawal Is a 'Dying Ember' While States Bet the Opposite Way
DEA's rescheduling hearing opened with sworn testimony dismissing cannabis withdrawal as trivial, while Georgia lifts its potency cap, Pennsylvania Democrats force a legalization vote, and cannabis stocks debut on the NYSE.
- Jul 2Harm Reduction
The DEA Learned From 2016 — This Time It's Only Banning Half the Plant
The DEA moved July 1, 2026 to temporarily ban concentrated 7-OH kratom extracts as Schedule I narcotics — not whole-leaf kratom. A decade after a near-identical ban on the whole plant collapsed under public pressure, the agency drew a narrower line. It's the right line. It's still not a plan.
- Jul 1Lived Experience & Community
The Relapse Trigger Nobody Screens For: Your Mailbox
A Yale addiction medicine fellow watched a stable patient unravel over an insurance premium hike, not a craving. Here's the psychology of why money fear hits recovery like a trigger — and what the research on post-acute withdrawal says about why you're still so raw a year in.
- Jul 1Arizona Watch
Tucson Built an Opioid Sobering Center That Works — Then Left It Two-Thirds Staffed
Pima County's SAFR Center is diverting people with opioid use disorder from jail and the ER with a 96% referral rate, but internal reporting shows only 11 of 19 staff positions filled and broken data tracking — with a one-year renewal decision due by September.
- Jul 1Treatment & Recovery
The World Has More Cocaine Than Ever, and Still Nothing to Prescribe For It
UNODC's World Drug Report 2026 shows cocaine production has quadrupled in a decade to 4,000 tonnes, with 25 million users worldwide. Cocaine still has no FDA-approved medication. Here's what actually helps.
- Jul 1Harm Reduction
Jails Are Killing People With a Drug Withdrawal They Refuse to Treat as Medicine
Medetomidine, a veterinary sedative cut into fentanyl, is causing cardiac arrests and strokes in jail withdrawal. Lab detections are up 33-fold in two years, and most county jails still aren't treating it as medicine.
June 2026
- Jun 30Science & Medicine
Psilocybin Just Got the Federal Fast-Track. The Science Is Further Along Than the Policy Knows.
In April 2026, President Trump signed an executive order directing federal agencies to expedite research, review, and access to psychedelic drugs — including psilocybin — as potential treatments fo...
- Jun 30Policy & Funding
RFK Jr. Announced $700 Million for Behavioral Health. Experts Say Most of It Already Existed.
On June 17, Secretary Robert F. Kennedy Jr. stood in front of cameras at a community behavioral health clinic in Clinton Township, Michigan, and announced "over $700 million in new funding" to addr...
- Jun 30Science & Medicine
Your Brain Did Not Fail You. It Did Exactly What Brains Do With Opioids.
A woman in Phoenix — her name is Maria, she told her story to a peer support program that has shared it publicly with her consent — went through opioid withdrawal for the fourth time at age 31. She...
- Jun 30The Crisis, By the Numbers
Overdose Deaths Fell 26% in One Year. Researchers Say the Reason Isn't What the Headlines Claim.
The headline number is a 26% drop.
- Jun 30Harm Reduction
SAMHSA Made It Cheaper to Die Than to Know What You're Dying From
On the morning of April 25, 2026, Shreeta Waldon opened an email that told her the $400,000 federal grant her organization had relied on for a year was gone. The Kentucky Harm Reduction Coalition h...
- Jun 29Daily Pulse
The Federal CM Cap Just Went Up 10x. Arizona Still Hasn't Applied for Medicaid Coverage.
The federal government raised the maximum contingency management incentive 10x in January 2025. A growing body of evidence shows CM reduces stimulant use and — in VA data — mortality by 41%. Arizona has not applied to CMS for Medicaid coverage.
- Jun 29Daily Pulse
HHS Announced $700 Million for Addiction This Week. The Same Administration Cut Fentanyl Test Strips.
HHS Secretary Kennedy announced $700M+ in new behavioral health funding on June 17 — the same week organizations reckoned with the April fentanyl test strip ban. The two actions aren't contradictory. They describe the same framework: treatment yes, harm reduction no.
- Jun 29Daily Pulse
Nitazenes Killed 409 People in 2024. That Number Is Already Out of Date.
Nitazene overdose deaths rose from 27 in 2020 to 409 in 2024 — a 1,400% increase in four years. With 26 compounds now detected in the U.S. supply, some more potent than fentanyl, the surveillance data is always a year late.